Treatment Preferences among Patients with Hormone-Sensitive Prostate Cancer in France, Spain, China, South Korea, and Japan: A Discrete-Choice Experiment
{{output}}
Background. Treatment preferences of patients with high-risk localized prostate cancer (HRLPC) and metastatic hormone-sensitive prostate cancer (mHSPC) are expected to be influenced by cultural and institutional differences across countries. We aimed to evalua... ...
